Annual Total Liabilities
$83.38 M
-$10.90 M-11.56%
31 December 2023
Summary:
Trinity Biotech annual total liabilities is currently $83.38 million, with the most recent change of -$10.90 million (-11.56%) on 31 December 2023. During the last 3 years, it has fallen by -$49.23 million (-37.12%). TRIB annual total liabilities is now -44.33% below its all-time high of $149.79 million, reached on 31 December 2015.TRIB Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Liabilities
$123.79 M
+$33.00 K+0.03%
30 September 2024
Summary:
Trinity Biotech quarterly total liabilities is currently $123.79 million, with the most recent change of +$33.00 thousand (+0.03%) on 30 September 2024. Over the past year, it has increased by +$42.70 million (+52.67%). TRIB quarterly total liabilities is now -19.98% below its all-time high of $154.70 million, reached on 30 June 2015.TRIB Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TRIB Total Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -11.6% | +52.7% |
| 3 y3 years | -37.1% | +1.5% |
| 5 y5 years | -22.5% | -7.8% |
TRIB Total Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -37.1% | at low | at high | +52.7% |
| 5 y | 5 years | -37.1% | at low | -9.1% | +52.7% |
| alltime | all time | -44.3% | +4804.9% | -20.0% | +7181.6% |
Trinity Biotech Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $123.79 M(+0.0%) |
| June 2024 | - | $123.75 M(+9.4%) |
| Mar 2024 | - | $113.16 M(+35.7%) |
| Dec 2023 | $83.38 M(-11.6%) | $83.38 M(+2.8%) |
| Sept 2023 | - | $81.08 M(-2.7%) |
| June 2023 | - | $83.37 M(-14.7%) |
| Mar 2023 | - | $97.78 M(+3.7%) |
| Dec 2022 | $94.28 M(-20.9%) | $94.28 M(+3.3%) |
| Sept 2022 | - | $91.26 M(-0.1%) |
| June 2022 | - | $91.32 M(-18.7%) |
| Mar 2022 | - | $112.38 M(-5.7%) |
| Dec 2021 | $119.21 M(-10.1%) | $119.21 M(-2.3%) |
| Sept 2021 | - | $121.97 M(-2.6%) |
| June 2021 | - | $125.22 M(-8.0%) |
| Mar 2021 | - | $136.11 M(+2.6%) |
| Dec 2020 | $132.62 M(+5.0%) | $132.62 M(+2.8%) |
| Sept 2020 | - | $129.00 M(-0.3%) |
| June 2020 | - | $129.44 M(+0.8%) |
| Mar 2020 | - | $128.36 M(+1.6%) |
| Dec 2019 | $126.36 M(+17.4%) | $126.36 M(-5.9%) |
| Sept 2019 | - | $134.32 M(+1.3%) |
| June 2019 | - | $132.63 M(+3.2%) |
| Mar 2019 | - | $128.48 M(+19.4%) |
| Dec 2018 | $107.61 M(-15.8%) | $107.61 M(-6.6%) |
| Sept 2018 | - | $115.24 M(-9.8%) |
| June 2018 | - | $127.75 M(-0.9%) |
| Mar 2018 | - | $128.90 M(+0.9%) |
| Dec 2017 | $127.78 M(-9.3%) | $127.78 M(-7.6%) |
| Sept 2017 | - | $138.24 M(+0.2%) |
| June 2017 | - | $137.93 M(+1.5%) |
| Mar 2017 | - | $135.86 M(-3.6%) |
| Dec 2016 | $140.87 M(-6.0%) | $140.87 M(-6.1%) |
| Sept 2016 | - | $150.07 M(+2.0%) |
| June 2016 | - | $147.11 M(-0.3%) |
| Mar 2016 | - | $147.56 M(-1.5%) |
| Dec 2015 | $149.79 M(+226.6%) | $149.79 M(+3.7%) |
| Sept 2015 | - | $144.38 M(-6.7%) |
| June 2015 | - | $154.70 M(+239.7%) |
| Mar 2015 | - | $45.54 M(-0.7%) |
| Dec 2014 | $45.87 M(+5.5%) | $45.87 M(+8.6%) |
| Sept 2014 | - | $42.22 M(-0.3%) |
| June 2014 | - | $42.34 M(+6.1%) |
| Mar 2014 | - | $39.90 M(-8.2%) |
| Dec 2013 | $43.48 M(+55.1%) | $43.48 M(-9.0%) |
| Sept 2013 | - | $47.75 M(+66.8%) |
| June 2013 | - | $28.63 M(-0.5%) |
| Mar 2013 | - | $28.78 M(+2.7%) |
| Dec 2012 | $28.03 M(+39.0%) | $28.03 M(+12.8%) |
| Sept 2012 | - | $24.85 M(+2.4%) |
| June 2012 | - | $24.27 M(+7.1%) |
| Mar 2012 | - | $22.67 M(+12.4%) |
| Dec 2011 | $20.17 M(+3.0%) | $20.17 M(-1.8%) |
| Sept 2011 | - | $20.54 M(-1.9%) |
| June 2011 | - | $20.94 M(-0.7%) |
| Mar 2011 | - | $21.08 M(+7.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2010 | $19.59 M(-63.1%) | $19.59 M(-7.8%) |
| Sept 2010 | - | $21.24 M(+3.3%) |
| June 2010 | - | $20.57 M(-59.1%) |
| Mar 2010 | - | $50.31 M(-5.3%) |
| Dec 2009 | $53.10 M(-16.5%) | $53.10 M(-2.0%) |
| Sept 2009 | - | $54.16 M(-8.3%) |
| June 2009 | - | $59.09 M(+3.1%) |
| Mar 2009 | - | $57.32 M(-9.9%) |
| Dec 2008 | $63.60 M(-19.6%) | $63.60 M(-6.2%) |
| Sept 2008 | - | $67.84 M(-2.3%) |
| June 2008 | - | $69.47 M(-6.3%) |
| Mar 2008 | - | $74.17 M(-6.3%) |
| Dec 2007 | $79.13 M(-3.3%) | $79.13 M(+9.1%) |
| June 2007 | - | $72.54 M(-4.3%) |
| Mar 2007 | - | $75.83 M(-7.4%) |
| Dec 2006 | $81.87 M(+60.6%) | $81.87 M(-0.8%) |
| Sept 2006 | - | $82.57 M(-0.0%) |
| June 2006 | - | $82.59 M(+91.5%) |
| Mar 2006 | - | $43.14 M(-15.4%) |
| Dec 2005 | $50.98 M(+47.0%) | $50.98 M(+9.6%) |
| Sept 2005 | - | $46.53 M(+37.7%) |
| June 2005 | - | $33.79 M(-2.2%) |
| Mar 2005 | - | $34.54 M(-0.4%) |
| Dec 2004 | $34.69 M(-8.3%) | $34.69 M(-6.3%) |
| Sept 2004 | - | $37.02 M(-2.9%) |
| June 2004 | - | $38.12 M(-5.1%) |
| Mar 2004 | - | $40.16 M(+6.2%) |
| Dec 2003 | $37.83 M(+40.4%) | $37.83 M(-4.1%) |
| Sept 2003 | - | $39.43 M(+85.5%) |
| June 2003 | - | $21.26 M(-19.1%) |
| Mar 2003 | - | $26.28 M(-2.5%) |
| Dec 2002 | $26.95 M(+31.5%) | $26.95 M(+31.6%) |
| Sept 2002 | - | $20.48 M(+10.1%) |
| June 2002 | - | $18.60 M(-9.4%) |
| Mar 2002 | - | $20.53 M(+0.1%) |
| Dec 2001 | $20.50 M(+68.2%) | $20.50 M(+61.1%) |
| Sept 2001 | - | $12.72 M(-8.9%) |
| June 2001 | - | $13.96 M(+21.2%) |
| Mar 2001 | - | $11.52 M(-5.5%) |
| Dec 2000 | $12.19 M(-45.4%) | $12.19 M(+11.1%) |
| Sept 2000 | - | $10.97 M(-22.9%) |
| June 2000 | - | $14.22 M(-35.2%) |
| Mar 2000 | - | $21.94 M(-1.7%) |
| Dec 1999 | $22.32 M(-26.6%) | $22.32 M(-18.8%) |
| Sept 1999 | - | $27.50 M(-8.0%) |
| June 1999 | - | $29.90 M(+6.8%) |
| Mar 1999 | - | $28.00 M(-7.9%) |
| Dec 1998 | $30.41 M(+73.8%) | $30.41 M(+2.1%) |
| Sept 1998 | - | $29.80 M(+63.7%) |
| June 1998 | - | $18.20 M(+4.0%) |
| Dec 1997 | $17.50 M(+548.1%) | $17.50 M(+548.1%) |
| Dec 1996 | $2.70 M(+58.8%) | $2.70 M(+58.8%) |
| Dec 1995 | $1.70 M(-5.6%) | $1.70 M(-5.6%) |
| Dec 1994 | $1.80 M(0.0%) | - |
| Feb 1994 | - | $1.80 M |
| Feb 1994 | $1.80 M | - |
FAQ
- What is Trinity Biotech annual total liabilities?
- What is the all time high annual total liabilities for Trinity Biotech?
- What is Trinity Biotech annual total liabilities year-on-year change?
- What is Trinity Biotech quarterly total liabilities?
- What is the all time high quarterly total liabilities for Trinity Biotech?
- What is Trinity Biotech quarterly total liabilities year-on-year change?
What is Trinity Biotech annual total liabilities?
The current annual total liabilities of TRIB is $83.38 M
What is the all time high annual total liabilities for Trinity Biotech?
Trinity Biotech all-time high annual total liabilities is $149.79 M
What is Trinity Biotech annual total liabilities year-on-year change?
Over the past year, TRIB annual total liabilities has changed by -$10.90 M (-11.56%)
What is Trinity Biotech quarterly total liabilities?
The current quarterly total liabilities of TRIB is $123.79 M
What is the all time high quarterly total liabilities for Trinity Biotech?
Trinity Biotech all-time high quarterly total liabilities is $154.70 M
What is Trinity Biotech quarterly total liabilities year-on-year change?
Over the past year, TRIB quarterly total liabilities has changed by +$42.70 M (+52.67%)